Back to top

Truist Financial Keeps Their Buy Rating on Agios Pharma (AGIO)

In a report released today, Gregory Renza from Truist Financial maintained a Buy rating on Agios Pharma, with a price target of $39.00. According t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Agios Pharmaceuticals, Inc. (AGIO)